Notorious vaccine skeptic RFK Jr finally urges people to get measles jab after deadly outbreak
Longtime vaccine skeptic Robert F Kennedy Jr has urged people to get the measles jab after a deadly outbreak in Texas – having initially downplayed the rapid spread of the infectious disease.
Writing in a Fox News op-ed Sunday, the freshly-confirmed Department of Health and Human Service secretary championed the measles, mumps and rubella vaccine, touting its efficacy against the deadly virus.
'Measles outbreak is call to action for all of us,' reads the title, with the standfirst stating: 'MMR vaccine is crucial to avoiding potentially deadly disease.' In the article's opening line, RFK Jr stated he is 'deeply concerned about the recent measles outbreak.'
He reflected on the days before the first measles vaccine was licensed for public use in the U.S. in 1963.
'Prior to the introduction of the (MMR) vaccine in the 1960s, virtually every child in the United States contracted measles,' RFK Jr citing that from 1953 to 1962, there were an average of 530,217 confirmed cases and 440 deaths – a one in 1,205 cases fatality rate.
The Kennedy scion said that it is the government's responsibility to ensure that accurate information is relayed about vaccine safety and efficacy, and pledged to 'make vaccines readily accessible for all those who want them.'
He added: 'Vaccines not only protect individual children from measles, but also contribute to community immunity, protecting those who are unable to be vaccinated due to medical reasons.
RFK Jr did, however, emphasize that the decision to vaccinate is 'a personal one.'
According to the latest figures from the Texas Department of Health and Human Services released Friday, 146 measles cases have been identified since late January – a majority of whom appear to be unvaccinated.
An unvaccinated school-age child in Lubbock marked the first death from the highly contagious virus last week and twenty other people have been hospitalized.
After the death Wednesday, the nation's top health official appeared to downplay the situation in Texas and described the outbreak as 'not unusual.'
'There have been four measles outbreaks this year in this country. Last year there were 16. So it's not unusual," he said during Donald Trump's first cabinet meeting. 'We have measles outbreaks every year.'
RFK Jr's latest remarks appear to mark a U-turn from his previous peddling of vaccine skepticism and conspiracy theories, including his promotion of the debunked idea that vaccines cause autism.
Along with his comments about vaccines and autism, the HHS secretary has made other historic inflammatory remarks, including suggesting in January 2022 that Anne Frank was in a better situation when she hid from Nazis than Americans were under Covid-19 mandates.
He also baselessly claimed that Covid-19 was a 'bioweapon' that targets 'Caucasians and Black people' while sparing Ashkenazi Jewish and Chinese people.
Spreading Covid-19 misinformation resulted in Meta deactivating his Instagram account in 2021.
During his Senate confirmation hearings last month, he attempted to clean up his previous remarks and insisted he is not anti-vaccine, but 'pro-safety.'
RFK Jr denied Oregon Senator Ron Wyden's accusations that he 'embraced conspiracy theories, quacks, charlatans, especially when it comes to the safety and efficacy of vaccines,' and noted his own children are vaccinated.
Vaccine hesitancy was already a concern before the Covid-19 pandemic and worsened during the vaccination campaigns, experts told the Washington Post.
According to a survey from the University of Pennsylvania's Annenberg Public Policy Center last June, nearly one in four respondents believed that the MMR vaccine caused autism.
The Centers for Disease Control and Prevention has said there is no evidence linking the measles vaccine and autism.
In August 2024, the findings from an Annenberg Science and Public Health survey suggested that more than a quarter of Americans believe that Covid-19 vaccines have caused thousands of deaths.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 minutes ago
- Yahoo
How AI could help stop the next pandemic before it starts
Could artificial intelligence tools be used to stop the next pandemic before it starts? During the Covid pandemic, new technology developed by researchers at Johns Hopkins and Duke universities didn't exist. But, for the first time, researchers there say they've devised a revolutionary large language modeling tool - the type of generative AI used in ChatGP - to help predict the spread of any infectious disease, such as bird flu, monkeypox, and RSV. That could help save lives and reduce infections. 'Covid-19 elucidated the challenge of predicting disease spread due to the interplay of complex factors that were constantly changing,' Johns Hopkins' Lauren Gardner, a modeling expert who created the Covid dashboard that was relied upon by people worldwide during the pandemic, said in a statement. 'When conditions were stable the models were fine. However, when new variants emerged or policies changed, we were terrible at predicting the outcomes because we didn't have the modeling capabilities to include critical types of information,' she added. 'The new tool fills this gap.' Gardner was one of the authors of the study published Thursday in the Nature Computational Science journal. The tool, named PandemicLLM, considers recent infection spikes, new variants, and stringent protective measures. The researchers utilized data that had never been used before in pandemic prediction tools, finding that PandemicLLM could accurately predict disease patterns and hospitalization trends one to three weeks out. The data included rates of cases hospitalizations and vaccines, types of government policies, characteristics of disease variants and their prevalence, and state-level demographics. The model incorporates these elements to predict how they will come together and affect how disease behaves. They retroactively applied PandemicLLM to the Covid pandemic, looking at each state over the course of 19 months. The authors said the tool was particularly successful when the outbreak was in flux. It also outperformed existing state-of-the-art forecasting methods, including the highest performing ones on the Centers for Disease Control and Prevention's CovidHub. 'Traditionally we use the past to predict the future,' author Hao 'Frank' Yang, a Johns Hopkins assistant professor of civil and systems engineering, said. 'But that doesn't give the model sufficient information to understand and predict what's happening. Instead, this framework uses new types of real-time information.' Going forward, they are looking at how large language models can replicate the ways individuals make decisions about their health. They hope that such a model would help officials to design safer and more effective policies. More than a million Americans have died from Covid. It's not a matter of if there will be a next pandemic, but when. Right now, the U.S. is dealing with the spread of H5N1 bird flu, RSV, HMPV, pertussis, and measles, among other health concerns. Vaccination rates for measles have plunged since the pandemic, and general vaccine hesitancy has increased. That has resulted in fears that the nation could see decades of health progress reversed. Furthermore, U.S. health officials have acted to separate from global efforts to respond to pandemics, withdrawing from the World Health Organization earlier this year. Last month, they limited access to Covid vaccines for certain groups. 'We know from Covid-19 that we need better tools so that we can inform more effective policies,' Gardner said. 'There will be another pandemic, and these types of frameworks will be crucial for supporting public health response.'
Yahoo
9 minutes ago
- Yahoo
GSK invests $300,000 to help launch the Pharmacy Innovation in Immunization Research Collaborative (PIIRC) at the University of Waterloo School of Pharmacy
PIIRC serves as a catalyst for innovation by supporting interdisciplinary research and real-world evidence generation focused on improving vaccine access, delivery and education. MISSISSAUGA, ON, June 6, 2025 /CNW/ - GSK is proud to announce a $300,000 investment in the Pharmacy Innovation in Immunization Research Collaborative (PIIRC), a new national initiative led by the School of Pharmacy at the University of Waterloo. This groundbreaking initiative reflects a shared commitment to expanding the role of pharmacy in Canada's immunization landscape and improving equitable access to vaccines across the country. Immunization has never been more critical. The COVID-19 pandemic underscored the life-saving power of vaccines and demonstrated the essential role that pharmacists and pharmacies play in public health. Pharmacy teams have administered more than 20 million COVID-19 vaccines in Canada alone. Yet, there remains untapped potential to leverage the country's 11,000+ pharmacies as accessible, community-based hubs for broader immunization services. PIIRC aims to close that gap. Launched by the largest clinical pharmacy practice research group in Canada, PIIRC serves as a catalyst for innovation by supporting interdisciplinary research and real-world evidence generation focused on improving vaccine access, delivery and education. The initiative brings together researchers from the University of Waterloo, national and international collaborators, policymakers and stakeholders across healthcare and industry to advance pharmacy-based immunization strategies. "As a global leader in vaccines, we believe in harnessing science and partnerships to tackle the world's most pressing health challenges," said Michelle Horn, Country Medical Director, GSK Canada. "Through our founding partnership with PIIRC, we are investing not only in research, but in the future of vaccine delivery in Canada—one that is more accessible, equitable, and community-centred." Transforming Immunization Through Pharmacy Innovation The objective of PIIRC is to re-imagine the role of pharmacy in immunization—from vaccine administration to health education, monitoring, and system design. Areas of research will include: Expanding the role of pharmacists and pharmacy technicians as vaccine educators, facilitators, and immunizers Overcoming barriers to access, especially among rural residents, older adults, immunocompromised individuals, and other underserved populations Leveraging digital health tools and technology to support clinical decision-making and personalized outreach Countering vaccine misinformation through evidence-based communication strategies and resources for healthcare providers Conducting economic analyses to examine the cost-effectiveness and public health value of pharmacy-based vaccine services Implementing science methodologies to ensure successful and scalable solutions across regions and populations This work will be supported by the School's extensive expertise in pharmacy practice research, health systems design, health economics, public policy, behavioural science, and communication strategies. "As a leader in clinical pharmacy practice research and community pharmacy innovation, the University of Waterloo's School of Pharmacy continues to push boundaries," said Andrea Edginton, Hallman Director, School of Pharmacy at the University of Waterloo. "PIIRC is a natural evolution of our work in immunization, and GSK's partnership will accelerate breakthroughs that improve public health both in Canada and globally." Impact Beyond the Lab In addition to funding innovative research, GSK's investment will also: Provide funding to support new interdisciplinary projects with direct policy and practice implications Train the next generation of immunization researchers, including PharmD students, graduate students and postdoctoral fellows Facilitate enhanced access to real-world pharmacy data to monitor vaccine uptake and identify areas for intervention Establish a network of community pharmacies engaged in research, data collection and pilot projects Enable regular knowledge translation activities to ensure research is informed by and disseminated to industry, government and community stakeholders Support the creation of an Advisory Board that includes voices from pharmaceutical and insurance companies, regulators, pharmacy associations and the public Strategic Alignment with Public Health and Policy This investment directly supports the Ontario Life Sciences Strategy by demonstrating private sector leadership in supporting community-based immunization services. By investing in evidence that shows how pharmacy can help achieve broader public health goals—including for future vaccine program rollouts such as RSV—GSK is playing a critical role in advancing both healthcare outcomes and policy development. "Our support for PIIRC is not just about generating data; it's about making a meaningful contribution to the future of healthcare," added Michelle Horn, Country Medical Director, GSK Canada. "We're proud to stand alongside the University of Waterloo School of Pharmacy in driving innovative, patient-centred immunization strategies that reflect our mission to get ahead of disease together and our commitment to doing what's right for communities and for public health." Why Waterloo and Why Now? The University of Waterloo's collaborative ethos, track record of external partnerships and commitment to impact make it an ideal home for PIIRC. The University creates substantial opportunities for high-impact partnerships that bridge the gap between research and application. PIIRC helps shape policy and guides decision-making with timely, actionable evidence that reflects the realities of patients, pharmacists and public health professionals. GSK's early and decisive investment solidifies its reputation as a forward-thinking leader in the pharmacy space and a partner of choice in advancing vaccine innovation. About the University of Waterloo School of PharmacyThe School of Pharmacy at the University of Waterloo is home to Canada's largest clinical pharmacy practice research group and is at the forefront of pharmacy innovation. Through interdisciplinary research and industry collaboration, the School is advancing pharmacy's role in improving health systems and patient outcomes. About GSK GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. Find out more at Cautionary statement regarding forward-looking statements GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described in the "Risk Factors" section in GSK's Annual Report on Form 20-F for 2024, and GSK's Q1 Results for 2025. SOURCE GlaxoSmithKline Inc. View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Gizmodo
16 minutes ago
- Gizmodo
Premature Newborn Dies in Ontario After Catching Measles From Unvaccinated Mother
A premature newborn in Ontario, Canada, has died after contracting measles—the first death this year linked to an ongoing outbreak of the vaccine-preventable disease in the country. Ontario health officials reported the death Thursday. The child caught the viral infection from their mother, who was not vaccinated from measles. Canada, the U.S., and Mexico have all faced surging outbreaks of measles in 2025, fueled by low vaccination rates in certain regions. 'It is with deep sadness that I confirm that an infant, born prematurely and infected with measles, has tragically passed away in southwestern Ontario,' said Kieran Moore, the chief medical officer of health in Ontario, in a statement. The ongoing measles outbreaks in North America are believed to have first started in Ontario last fall. By January 2025, measles began to hit parts of Texas, with cases eventually spreading to nearby states and Northern Mexico. The outbreaks have largely occurred in rural Mennonite communities where people often forego routine vaccinations and other healthcare services provided by outside doctors. The U.S. and Mexico have each reported around 1,000 cases of measles this year, while over 2,700 cases have been reported in Canada, mostly in Ontario. But these numbers are almost certainly an underestimate of the problem. According to Moore, the child contracted measles while in the womb, which may have contributed to their premature birth. The child did have other medical complications unrelated to the virus, however, so it's possible that the infection may not have been the primary or sole factor behind their death. Measles in general has a very low fatality rate, but it's highly contagious among unvaccinated people and is known to be more dangerous to developing fetuses and very young children. Over 100,000 people died from measles globally in 2023, according to the World Health Organization, most of whom were children under the age of five. Though this is Canada's first death linked to measles this year, it's not the first in North America. There have been three confirmed measles deaths in the U.S. so far, while more than 100 people (mostly children) have been hospitalized. Unlike the latest death, two of these U.S. deaths occurred in children with no pre-existing health issues. Measles has been resurgent in much of the world as of late, aided by declining vaccination rates. But while this problem has been building up over time, the situation in the U.S. is only expected to worsen under the current presidential administration. Many of President Donald Trump's appointees—in particular Health and Human Services Secretary Robert F. Kennedy Jr.—have regularly spread misinformation about the safety of vaccines, including the combination measles, mumps, and rubella vaccine. Kennedy has both downplayed the ongoing outbreaks and supported dubious measles treatments with little to no evidence behind them, such as cod liver oil supplements. Many Americans today remain woefully in the dark about the severity of these outbreaks and the importance of vaccination. 'Anyone who is unvaccinated is at risk and I urge everyone, but especially those who may become pregnant, to ensure they have received two doses of the MMR vaccine, which will protect both a parent and baby. This vaccine has been safely used for over 50 years and is highly effective,' Moore noted in his announcement of the child's death.
